Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors
Abstract Background The use of historical external control data in clinical trials has grown in interest and needs when considering the design of future trials. Hybrid control designs can be more efficient to achieve the same power with fewer patients and limited resources. The literature is sparse...
Saved in:
| Main Authors: | Emily M. Damone, Jiawen Zhu, Herbert Pang, Xiao Li, Yinqi Zhao, Evan Kwiatkowski, Lisa A. Carey, Joseph G. Ibrahim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Medical Research Methodology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12874-024-02383-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research beyond Randomised Controlled Trial: The Importance of Pragmatic Clinical Trials for Generating Real-world Evidence in Current Healthcare
by: Sangita Jogdand, et al.
Published: (2025-03-01) -
Decentralized clinical trials: regulatory perspectives in Russia and the EAEU
by: M. A. Borzova, et al.
Published: (2023-08-01) -
Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01) -
Considerations for the design and conduct of externally controlled trials for drug and biological products
by: A. S. Motrinchuk, et al.
Published: (2023-12-01) -
Assessing the replicability of RCTs in RWE emulations
by: Jeanette Köppe, et al.
Published: (2025-05-01)